Crystal Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 11-12-2024
- Paid Up Capital ₹ 2.49 M
as on 11-12-2024
- Company Age 36 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 1.79 Cr
as on 11-12-2024
- Revenue 7.10%
(FY 2020)
- Profit 93.41%
(FY 2020)
- Ebitda 76.46%
(FY 2020)
- Net Worth -1.26%
(FY 2020)
- Total Assets -19.95%
(FY 2020)
About Crystal Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.49 M.
The company has closed loans amounting to ₹1.79 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ashwath Irkal and Rajendra Irkal serve as directors at the Company.
- CIN/LLPIN
U24232GA1988PTC000834
- Company No.
000834
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jun 1988
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
Goa, Goa, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Crystal Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashwath Irkal  | Director | 14-Sep-2019 | Current |
| Rajendra Irkal | Director | 14-Sep-2019 | Current |
Financial Performance of Crystal Pharma.
Crystal Pharma Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 7.1% increase. The company also saw a substantial improvement in profitability, with a 93.41% increase in profit. The company's net worth dipped by a decrease of 1.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Crystal Pharma?
In 2020, Crystal Pharma had a public holding of 2.09%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Shamrao Vithal Co-Operative Bank Limited Creation Date: 25 Mar 2010 | ₹1.38 M | Satisfied |
The Shamrao Vithal Co-Operative Bank Limited Creation Date: 03 Jun 2009 | ₹3.81 M | Satisfied |
The Shamrao Vithal Co-Operative Bank Limited Creation Date: 14 Feb 2008 | ₹0.53 M | Satisfied |
How Many Employees Work at Crystal Pharma?
Crystal Pharma has a workforce of 11 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Crystal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crystal Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
